U.S. Health and Human Services Secretary Robert F. Kennedy Jr. is facing backlash after firing all 17 members of the CDC’s Advisory Committee on Immunization Practices (ACIP) and replacing them with eight new members, several of whom have histories of vaccine skepticism. The move has raised concerns among public health experts and lawmakers, including Senator Bill Cassidy, a Republican and physician from Louisiana who chairs the Senate Health Committee.
Cassidy had previously supported Kennedy's confirmation after receiving assurances that the ACIP structure would remain intact. “If confirmed, he will maintain the CDC’s ACIP without changes,” Cassidy had said during a Senate floor speech. However, Kennedy now says he only promised to let Cassidy choose one candidate for the panel, a pledge he intends to honor.
During a Fox News interview, Kennedy denied violating any agreement. “I told Senator Cassidy I would allow him to put one of his candidates on, which we’re going to do,” he stated. Cassidy’s office later clarified the commitment was about maintaining the ACIP process, not preventing staff changes.
Kennedy defended his decision, citing alleged conflicts of interest among the previous members, though he offered no specific evidence. His reshuffle has drawn sharp criticism from the American Medical Association, which called for an investigation and a reversal of the firings. Critics argue that stacking the panel with vaccine skeptics could undermine public trust in immunization policy.
The ACIP plays a key role in advising the CDC on who should receive vaccines after FDA approval. The controversy has intensified scrutiny of Kennedy’s long-standing views on vaccines, which often contradict mainstream medical consensus. With political and public health stakes high, the debate over ACIP’s direction is far from over.


European Leaders Launch International Claims Commission to Compensate Ukraine for War Damage
Federal Judge Blocks Trump Administration’s Pause on New Wind-Energy Permits
Syria Arrests Five Suspects After Deadly Attack on U.S. and Syrian Troops in Palmyra
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
U.S. State Department Reverts to Times New Roman in Push for “Professionalism”
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
Senate Set for Vote on GOP Healthcare Plan as Debate Over ACA Subsidies Intensifies
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development
Trump Weighs Reclassifying Marijuana as Schedule III, Potentially Transforming U.S. Cannabis Industry
Taiwan Political Standoff Deepens as President Lai Urges Parliament to Withdraw Disputed Laws
EU Court Cuts Intel Antitrust Fine to €237 Million Amid Long-Running AMD Dispute
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Federal Judge Orders Restoration of SEVIS Status for Tufts PhD Student Rumeysa Ozturk
U.S. Greenlights Nvidia H200 Chip Exports to China With 25% Fee
U.S. Military Bill Seeks to End Dependence on China for Display Technology by 2030 



